<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:sdc="http://www.alacra.com/sdc" ><channel><title>Zenotech Laboratories Ltd RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Zenotech Laboratories Ltd</description>
<link>http://www.alacrastore.com/company-snapshot/Zenotech_Laboratories_Ltd-4022142</link>
<lastBuildDate>Friday, October 10, 2008 10:59:52 PM</lastBuildDate>
<alacra:xlsid>4022142</alacra:xlsid>
<alacra:company>Zenotech Laboratories Ltd</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><title>Daiichi Sankyo Co Ltd acquires a minority stake in Zenotech Laboratories Ltd</title><description>INDIA - Daiichi Sankyo Co Ltd (DS) planned to launch a tender offer to acquire a ##% stake, or #.## mil ordinary shares, in Zenotech Laboratories Ltd, a pharmaceuticals manufacturer and wholesaler. Concurrently, DS agreed to acquire ordinary shares and warrants convertible into a ##.##%, or ###.### mil new ordinary shares, in Ranbaxy Laboratories Ltd (RL). Subsequently, DS planned to launch a mandatory tender offer to raise its interest to ##.##% from ##.##% by acquiring a further ##% stake, or ##.### mil ordinary shares, in RL.</description><pubDate>6/12/2008 3:24:21 PM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">23186L</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">98827W</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">23186L</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">98827W</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">Daiichi Sankyo Co Ltd</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">Zenotech Laboratories Ltd</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">Daiichi Sankyo Co Ltd</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">Zenotech Laboratories Ltd</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/Daiichi_Sankyo_Co_Ltd_acquires_a_minority_stake_in_Zenotech_Laboratories_Ltd-1985616040</link><guid isPermaLink="false">sdc/1985616040</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>1985616040</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_EXCHANGE><sdc:value>Tokyo 1</sdc:value></sdc:a_EXCHANGE><sdc:a_MAINDUSTRY><sdc:value>Drugs</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>Japan</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Pharmaceutical preparations</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>2834</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>FF</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>Foreign</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Public</sdc:value></sdc:a_STATUS><sdc:a_TICKER><sdc:value>4568</sdc:value></sdc:a_TICKER><sdc:asic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2879:Pesticides and agricultural chemicals, nec</sdc:value><sdc:value sdc:p="3">5122:Drugs, drug proprietaries, and druggists' sundries</sdc:value><sdc:value sdc:p="4">5191:Farm supplies</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2879:Pesticides and agricultural chemicals, nec</sdc:value><sdc:value sdc:p="3">5122:Drugs, drug proprietaries, and druggists' sundries</sdc:value><sdc:value sdc:p="4">5191:Farm supplies</sdc:value></sdc:aupsic_SIC><sdc:b_EXCHANGE><sdc:value>Bombay</sdc:value></sdc:b_EXCHANGE><sdc:b_MAINDUSTRY><sdc:value>Drugs</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>India</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Pharmaceutical preparations</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>2834</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>FF</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>Foreign</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Public</sdc:value></sdc:b_STATUS><sdc:b_TICKER><sdc:value>532039</sdc:value></sdc:b_TICKER><sdc:c_ACIDGEN><sdc:value>5310002</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Mnfr,whl pharm</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Mnfr,whl pharm</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value>Unspecified</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Ordinary Share</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>395276003</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>Jun 12 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>0.00000</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>0.00000</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.00000</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>0.00000</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>0.00000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>0.00000</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>0.00000</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>0.00000</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>0.00000</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_RATE><sdc:value>0.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value><sdc:value sdc:p="15">16.00000</sdc:value><sdc:value sdc:p="16">17.00000</sdc:value><sdc:value sdc:p="17">18.00000</sdc:value><sdc:value sdc:p="18">19.00000</sdc:value><sdc:value sdc:p="19">20.00000</sdc:value><sdc:value sdc:p="20">21.00000</sdc:value><sdc:value sdc:p="21">22.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">Daiichi Sankyo Co Ltd,</sdc:value><sdc:value sdc:p="1">headquartered in Tokyo, Japan,</sdc:value><sdc:value sdc:p="2">manufactures and distributes</sdc:value><sdc:value sdc:p="3">pharmaceuticals, medical</sdc:value><sdc:value sdc:p="4">surgical supplies,</sdc:value><sdc:value sdc:p="5">agrochemical, foods,</sdc:value><sdc:value sdc:p="6">cosmetics, synthetic and</sdc:value><sdc:value sdc:p="7">industrial chemicals and</sdc:value><sdc:value sdc:p="8">related products. Operations</sdc:value><sdc:value sdc:p="9">are carried out through the</sdc:value><sdc:value sdc:p="10">following sectors:</sdc:value><sdc:value sdc:p="11">pharmaceuticals and others.</sdc:value><sdc:value sdc:p="12">The pharmaceuticals include</sdc:value><sdc:value sdc:p="13">general medicines. The other</sdc:value><sdc:value sdc:p="14">division deals with foods such</sdc:value><sdc:value sdc:p="15">as foods and food additives,</sdc:value><sdc:value sdc:p="16">agriculture related products</sdc:value><sdc:value sdc:p="17">such as insecticides and</sdc:value><sdc:value sdc:p="18">others such as chemicals,</sdc:value><sdc:value sdc:p="19">animal medicines, feeds</sdc:value><sdc:value sdc:p="20">sundries and car leasing. The</sdc:value><sdc:value sdc:p="21">company was founded in 2005.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value sdc:p="0">Daiichi Sankyo Co Ltd, headquartered in Tokyo, Japan,</sdc:value><sdc:value sdc:p="1">manufactures and distributes pharmaceuticals, medical</sdc:value><sdc:value sdc:p="2">surgical supplies, agrochemical, foods, cosmetics, synthetic</sdc:value><sdc:value sdc:p="3">and industrial chemicals and related products. Operations</sdc:value><sdc:value sdc:p="4">are carried out through the following sectors:</sdc:value><sdc:value sdc:p="5">pharmaceuticals and others. The pharmaceuticals include</sdc:value><sdc:value sdc:p="6">general medicines. The other division deals with foods such</sdc:value><sdc:value sdc:p="7">as foods and food additives, agriculture related products</sdc:value><sdc:value sdc:p="8">such as insecticides and others such as chemicals, animal</sdc:value><sdc:value sdc:p="9">medicines, feeds sundries and car leasing. The company was</sdc:value><sdc:value sdc:p="10">founded in 2005.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>Daiichi Sankyo Co Ltd, headquartered in Tokyo, Japan, manufactures and distributes pharmaceuticals, medical surgical supplies, agrochemical, foods, cosmetics, synthetic and industrial chemicals and related products. Operations are carried out through the following sectors: pharmaceuticals and others. The pharmaceuticals include general medicines. The other division deals with foods such as foods and food additives, agriculture related products such as insecticides and others such as chemicals, animal medicines, feeds sundries and car leasing. The company was founded in 2005.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">Zenotech Laboratories Ltd,</sdc:value><sdc:value sdc:p="1">located in Hyderabad, India,</sdc:value><sdc:value sdc:p="2">manufactures and wholesales</sdc:value><sdc:value sdc:p="3">pharmaceuticals. The Group</sdc:value><sdc:value sdc:p="4">operates at Brazil, Nigeria,</sdc:value><sdc:value sdc:p="5">U.S.A. and other countries.</sdc:value><sdc:value sdc:p="6">The company was founded in</sdc:value><sdc:value sdc:p="7">1989.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">Zenotech Laboratories Ltd, located in Hyderabad, India,</sdc:value><sdc:value sdc:p="1">manufactures and wholesales pharmaceuticals. The Group</sdc:value><sdc:value sdc:p="2">operates at Brazil, Nigeria, U.S.A. and other countries. The</sdc:value><sdc:value sdc:p="3">company was founded in 1989.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>Zenotech Laboratories Ltd, located in Hyderabad, India, manufactures and wholesales pharmaceuticals. The Group operates at Brazil, Nigeria, U.S.A. and other countries. The company was founded in 1989.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>0.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>0.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>34.30000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>Y</sdc:value></sdc:i_CROSS1><sdc:i_DATEANN><sdc:value>11 Jun 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Wed, 11 Jun 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 06/11/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFFS><sdc:value>Date Effective:</sdc:value></sdc:i_DATEEFFS><sdc:i_DESCR><sdc:value>Acq. Part. Int.</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Friendly</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>0.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>0.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>0.00000</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>0.00000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>0</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>0.00000</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>0.00000</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>0</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>0.00000</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>0.00000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>0.00000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>0.00000</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>0.00000</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>0.00000</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>0</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>0.00000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>0.00000</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>0.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>0.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>0.00000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>0.00000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>0.00000</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>0.00000</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>0.00000</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>0.00000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>20.00000</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>0.00000</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>0.00000</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>0.00000</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>0.00000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>0.00000</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>0.00000</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value><sdc:value sdc:p="15">16.00000</sdc:value><sdc:value sdc:p="16">17.00000</sdc:value><sdc:value sdc:p="17">18.00000</sdc:value><sdc:value sdc:p="18">19.00000</sdc:value><sdc:value sdc:p="19">20.00000</sdc:value><sdc:value sdc:p="20">21.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">INDIA - Daiichi Sankyo Co Ltd</sdc:value><sdc:value sdc:p="1">(DS) planned to launch a</sdc:value><sdc:value sdc:p="2">tender offer to acquire a 20%</sdc:value><sdc:value sdc:p="3">stake, or 6.86 mil ordinary</sdc:value><sdc:value sdc:p="4">shares, in Zenotech</sdc:value><sdc:value sdc:p="5">Laboratories Ltd, a</sdc:value><sdc:value sdc:p="6">pharmaceuticals manufacturer</sdc:value><sdc:value sdc:p="7">and wholesaler. Concurrently,</sdc:value><sdc:value sdc:p="8">DS agreed to acquire ordinary</sdc:value><sdc:value sdc:p="9">shares and warrants</sdc:value><sdc:value sdc:p="10">convertible into a 45.13%, or</sdc:value><sdc:value sdc:p="11">200.029 mil new ordinary</sdc:value><sdc:value sdc:p="12">shares, in Ranbaxy</sdc:value><sdc:value sdc:p="13">Laboratories Ltd (RL).</sdc:value><sdc:value sdc:p="14">Subsequently, DS planned to</sdc:value><sdc:value sdc:p="15">launch a mandatory tender</sdc:value><sdc:value sdc:p="16">offer to raise its interest to</sdc:value><sdc:value sdc:p="17">65.13% from 45.13% by</sdc:value><sdc:value sdc:p="18">acquiring a further 20% stake,</sdc:value><sdc:value sdc:p="19">or 88.649 mil ordinary shares,</sdc:value><sdc:value sdc:p="20">in RL.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>INDIA - Daiichi Sankyo Co Ltd (DS) planned to launch a tender offer to acquire a 20% stake, or 6.86 mil ordinary shares, in Zenotech Laboratories Ltd, a pharmaceuticals manufacturer and wholesaler. Concurrently, DS agreed to acquire ordinary shares and warrants convertible into a 45.13%, or 200.029 mil new ordinary shares, in Ranbaxy Laboratories Ltd (RL). Subsequently, DS planned to launch a mandatory tender offer to raise its interest to 65.13% from 45.13% by acquiring a further 20% stake, or 88.649 mil ordinary shares, in RL.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">INDIA - Daiichi Sankyo Co Ltd (DS) planned to launch a tender offer to acquire a 20%</sdc:value><sdc:value sdc:p="1">stake, or 6.86 mil ordinary shares, in Zenotech Laboratories Ltd, a pharmaceuticals</sdc:value><sdc:value sdc:p="2">manufacturer and wholesaler. Concurrently, DS agreed to acquire ordinary shares and</sdc:value><sdc:value sdc:p="3">warrants convertible into a 45.13%, or 200.029 mil new ordinary shares, in Ranbaxy</sdc:value><sdc:value sdc:p="4">Laboratories Ltd (RL). Subsequently, DS planned to launch a mandatory tender offer to</sdc:value><sdc:value sdc:p="5">raise its interest to 65.13% from 45.13% by acquiring a further 20% stake, or 88.649 mil</sdc:value><sdc:value sdc:p="6">ordinary shares, in RL.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value sdc:p="0">INDIA - Daiichi Sankyo Co Ltd (DS) planned to launch a tender offer to acquire a 20% stake, or 6.86 mil ordinary shares, in Zenotech Laboratories Ltd, a pharmaceuticals manufacturer and wholesaler.</sdc:value><sdc:value sdc:p="1">Concurrently, DS agreed to acquire ordinary shares and warrants convertible into a 45.13%, or 200.029 mil new ordinary shares, in Ranbaxy Laboratories Ltd (RL). Subsequently, DS planned to launch a</sdc:value><sdc:value sdc:p="2">mandatory tender offer to raise its interest to 65.13% from 45.13% by acquiring a further 20% stake, or 88.649 mil ordinary shares, in RL.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">INDIA - Daiichi Sankyo Co Ltd (DS) planned to launch a tender offer to acquire a 20% stake, or 6.86 mil ordinary shares, in Zenotech</sdc:value><sdc:value sdc:p="1">Laboratories Ltd, a pharmaceuticals manufacturer and wholesaler. Concurrently, DS agreed to acquire ordinary shares and warrants</sdc:value><sdc:value sdc:p="2">convertible into a 45.13%, or 200.029 mil new ordinary shares, in Ranbaxy Laboratories Ltd (RL). Subsequently, DS planned to launch a</sdc:value><sdc:value sdc:p="3">mandatory tender offer to raise its interest to 65.13% from 45.13% by acquiring a further 20% stake, or 88.649 mil ordinary shares, in</sdc:value><sdc:value sdc:p="4">RL.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Intended</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>0.00000</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>0.00000</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Intended</sdc:value></sdc:q_STATUS><sdc:r_PE><sdc:value>-999.00000</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>np</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>-999.00000</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>np</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>0.00000</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>0.00000</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>0.00000</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value sdc:p="0">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="1">2836:Biological products, except diagnostic substances</sdc:value><sdc:value sdc:p="2">5122:Drugs, drug proprietaries, and druggists' sundries</sdc:value><sdc:value sdc:p="3">5912:Drug stores and proprietary stores</sdc:value><sdc:value sdc:p="4">8071:Medical laboratories</sdc:value><sdc:value sdc:p="5">8731:Commercial physical and biological research</sdc:value><sdc:value sdc:p="6">8733:Noncommercial research organizations</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>5310002</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_EXCHANGE><sdc:value>Tokyo 1</sdc:value></sdc:upa1_EXCHANGE><sdc:upa1_NATION><sdc:value>Japan</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>2834</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>Foreign</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Public</sdc:value></sdc:upa1_STATUS><sdc:upa1_TICKER><sdc:value>4568</sdc:value></sdc:upa1_TICKER><sdc:upsic_SIC><sdc:value sdc:p="0">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="1">2836:Biological products, except diagnostic substances</sdc:value><sdc:value sdc:p="2">5122:Drugs, drug proprietaries, and druggists' sundries</sdc:value><sdc:value sdc:p="3">5912:Drug stores and proprietary stores</sdc:value><sdc:value sdc:p="4">8071:Medical laboratories</sdc:value><sdc:value sdc:p="5">8731:Commercial physical and biological research</sdc:value><sdc:value sdc:p="6">8733:Noncommercial research organizations</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>395276003</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_EXCHANGE><sdc:value>Bombay</sdc:value></sdc:upt1_EXCHANGE><sdc:upt1_NATION><sdc:value>India</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>2834</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>Foreign</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Public</sdc:value></sdc:upt1_STATUS><sdc:upt1_TICKER><sdc:value>532039</sdc:value></sdc:upt1_TICKER><sdc:x_RANK1_VALUE><sdc:value>0.00000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>0.00000</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>0.00000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>0.00000</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>TF Mergers &amp; Acquisitions</alacra:ip></item></channel></rss>